Novel study aims to develop personalized treatment for triple-negative breast cancer

By | November 9, 2021
Indiana University School of Medicine researcher Bryan P. Schneider, MD, is leading a novel nationwide study to better understand how to treat patients with triple-negative breast cancer based on their own unique genetic data.